The application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patients

Lasers in Medical Science

Volumn 28, Issue 4, 2013, Pages 1151-1157

  Tao, Wei ^a   Xue, Boxin ^a   Zang, Yachen ^a   Sun, Chuanyang ^a   Yang, Dongrong ^a   Zhang, Yuanyuan ^b   Shan, Yuxi ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Anticoagulants; Benign prostatic hyperplasia; Cardiovascular disease; Laser surgery

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; M ACCEPTOR BLOCKER; PHOSPHORIC ACID DERIVATIVE; POTASSIUM TITANYL PHOSPHATE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; URINARY TRACT AGENT;

AGED; ARTICLE; BLADDER CATHETERIZATION; BLADDER DISEASE; BLADDER IRRIGATION; BLADDER NECK CONTRACTURE; BLEEDING DISORDER; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; DYSURIA; HEMATURIA; HIGH RISK PATIENT; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LASER PROSTATECTOMY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROSTATE LASER VAPORIZATION; PROSTATE VOLUME; PROTEIN BLOOD LEVEL; REOPERATION; RISK ASSESSMENT; TRANSURETHRAL RESECTION; URETHRA STRICTURE; URETHRAL CATHETERIZATION; URGE INCONTINENCE; URINARY TRACT INFECTION; URINE RETENTION;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DYSURIA; HUMANS; LASER THERAPY; LASERS, SOLID-STATE; MALE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; RISK FACTORS; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 84879838379     PISSN: 02688921     EISSN: 1435604X     Source Type: Journal    
DOI: 10.1007/s10103-012-1212-2     Document Type: Article

References (39)

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474-479
2. Souverein PC, Erkens JA, de la Rosette JJMCH, Leufkens HGM, Herings RMC (2003) Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery. Eur Urol 43:528-534
3. Amen-Plama JA, Arteaga RB (2001) Hemostatic technique: extracapsular prostatic adenomectomy. J Urol 166:1364-1367
4. Mebust WK et al (1998) Transurethral surgery. In: Walsh PC, Retik AB, Vaughan ED Jr (eds) Cambells' Urology, 7th edn. WB Saunders, Philadelphia, pp 1511-1528
5. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T (2005) High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173:158-160
6. AUA Practice Guidelines Committee (2003) AUA guideline on management of benign prostatic hyperplasia: diagnosis and treatment recommendations. J Urol 170:530-547
7. Cleynenbreuel BV, Srirangam SJ, Van Poppel H (2009) High performance system Greenlight laser: indications and outcomes. Curr Opin Urol 19:33-37
8. Costello AJ, Bowsher WG, Bolton DM, Braslis KG, Burt J (1992) Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 69:603-608
9. Muschter R, Hofstetter A (1995) Interstitial laser therapy outcomes in benign prostatic hyperplasia. J Endourol 9:129-135
10. Malek RS (2008) GreenLight™ HPS laser therapy for BPH: clinical outcomes and surgical recommendations from the International GreenLight User (IGLU) group. Eur Urol Suppl 7:361-362
11. Bachmann A, Schurch L, Ruszat R et al (2005) Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48:965-972
12. Bachmann A, Ruszat R, Wyler S et al (2005) Photoselective vaporization of the prostate: the Basel experience after 108 procedures. Eur Urol 47:798-804
13. Tugcu V, TascI AI, Sahin S, Ordekci Y, Karakas OF, Zorluoglu F (2007) Outcomes of 80 W KTP laser vaporization of the large prostate. Urol Int 79:316-320
14. Volkan T, Ihsan TA, YIlmaz O et al (2005) Short term outcomes of high power (80-W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 48:608-613
15. Tugcu V, TascI AI, Sahin S, Zorluoglu F (2008) Rapid communication: photoselective vaporization of the prostate verus transurethral resection of the prostate for the large prostate: a prospective nonrandomised bicenter trial with 2-year follow-up. J Endourol 22:347-353
16. Sountoulides P, Tsakiris P (2008) The evolution of KTP laser vaporization of the prostate. Yonsei Med J 49:189-199
17. Tzortzis V, Gravas S, de la Rosette-Jean JMCH (2009) Minimally invasive surgical treatments for benign prostatic hyperplasia. Eur Urol Suppl 8:513-522
18. TasçI AL, Ilbey YÖ, Luleci H et al (2011) 120-W Greenlight laser photoselective vaporization of prostate for benign prostatic hyperplasia: midterm outcomes. Urology 78:134-141
19. Al-Ansari A, Younes N, Sampige VP et al (2010) Greenlight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58:349-355
20. Capitan C, Blazquez C, Martin MD, Hernandez V, de la Pena E, Llorente C (2011) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 60:734-739
21. Spaliviero M, Araki M, Wong C (2008) Short-term outcomes of Greenlight HPSTM laser photoselective vaporization of prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol 22:2341-2347
22. Saklad M (1941) Grading of patients for surgical procedures. Anesthesiology 2:281-284
23. Malek RS, Barrett DM, Kuntzman RS (1998) High-power potassium-titanyl- phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 51:254-256
24. Malek RS, Kuntzman RS, Barrett DM (2000) High power potassium-titanyl- phosphate laser vaporization prostatectomy. J Urol 163:1730-1733
25. Hai MA, Malek RS (2003) Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 17:93-96
26. Malek RS, Nahen K (2004) Photoselective vaporization of the prostate (PVP): KTP laser therapy of obstructive benign prostatic hyperplasia. AUA Update 23:153-155
27. Te AE, Malloy TR, Stein BS et al (2004) Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the First United States Multicenter Prospective Trial. J Urol 172:1404-1408
28. Bachmann A, Schürch L, Ruszat R, Wyler SF (2005) Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48:965-972
29. Malek RS, Kuntzman RS, Barrett DM (2005) Photoselective potassiumtitanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 174:1344-1348
30. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA (2006) Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 97:1229-1233
31. Roehrborn CG (2006) Safety and efficacy of the potassium-titanyl- phosphate laser and photoselective vaporization of the prostate for benign prostatic hyperplasia. Rev Urol 8:S16-S23
32. Woo H, Reich O, Bachmann A et al (2008) Outcomes of GreenLight HPS 120-W laser therapy in specific patients populations: those in retention, on anticoagulants, and with large prostates (>80 mL). Eur Urol Suppl 7:378-383
33. Tugcu V, Tasci AI, Sahin S, Zorluoglu F (2008) Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 22:1519-1525
34. Ruszat R, Seitz M, Wyler SF et al (2008) Greenlight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 54:893-901
35. Ruszat R, Wyler SF, Seitz M et al (2008) Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-center study. BJU Int 102:1432-1439
36. Huang ST, Cai X, Ii X et al (2008) Greenlight photoselective vaporization of prostate for treatment of high-risk older patients with benign prostatic hyperplasia (report of 30 cases). Clini Med 28:25-26
37. Te AE (2006) The next generation in laser treatments and the role of the GreenLight high-performance system laser. Rev Urol 8:S24-S30
38. Ruszat R, Wyler S, Forster T et al (2007) Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 51:1031-1041
39. Dotan ZA, Mor Y, Leibovitch I et al (2003) The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol 168:610-614